Biden forming nonprofit to focus on cancer issues after leaving White House

Outgoing Vice President Joe Biden will continue to advocate for changes in cancer research and treatment once he leaves political office by creating a new nonprofit organization.

“I’m going to begin a national conversation and get Congress and advocacy groups in to make sure these treatments are accessible to everyone, including these vulnerable underserved populations, and that we have a more rational way of paying for them while promoting innovation,” Biden said in a Washington Post interview.

Biden was put in charge of President Barack Obama’s cancer “moonshot” after his son Beau died of brain cancer in 2015. He plans on continuing the objectives of that initiative—like finding new ways to improve oncology treatment—while expanding the mission with new priorities, like lowering the cost of cancer drugs.

Pharmaceutical companies are already taking notice of Biden’s plans. Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.